President Trump has proposed a one hundred per cent tariff on branded and patented pharmaceutical imports, due to take effect unless manufacturers shift production to the United States by October 2025. The measure is part of a wider plan to rebuild domestic manufacturing and reduce the US trade deficit. Officials say it will strengthen national security, but the pharmaceutical industry has warned of major disruption to global supply chains and rising drug prices across Europe and beyond. ...
All content for The Commercial Awareness Compass by AllAboutLaw is the property of AllAboutLaw and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
President Trump has proposed a one hundred per cent tariff on branded and patented pharmaceutical imports, due to take effect unless manufacturers shift production to the United States by October 2025. The measure is part of a wider plan to rebuild domestic manufacturing and reduce the US trade deficit. Officials say it will strengthen national security, but the pharmaceutical industry has warned of major disruption to global supply chains and rising drug prices across Europe and beyond. ...
Compliance crunch: insurers caught between growth and trust | Commercial Awareness Compass #52
The Commercial Awareness Compass by AllAboutLaw
39 minutes
1 month ago
Compliance crunch: insurers caught between growth and trust | Commercial Awareness Compass #52
The UK’s insurance sector is facing one of its most significant regulatory shifts since the 2008 financial crisis. The Prudential Regulation Authority (PRA) and Financial Conduct Authority (FCA) are consulting on proposals to simplify rules, speed up approvals, and free up capital to make the UK a more competitive financial hub. But these changes come with risks. The regulators are juggling conflicting priorities: protect consumers or unlock growth? If capital requirements are eased, insurer...
The Commercial Awareness Compass by AllAboutLaw
President Trump has proposed a one hundred per cent tariff on branded and patented pharmaceutical imports, due to take effect unless manufacturers shift production to the United States by October 2025. The measure is part of a wider plan to rebuild domestic manufacturing and reduce the US trade deficit. Officials say it will strengthen national security, but the pharmaceutical industry has warned of major disruption to global supply chains and rising drug prices across Europe and beyond. ...
